Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Glitazones may have ability to inhibit tumor growth,
Read More »Issue 174 Item 8 Patient Education Succeeds Even in Diabetes Capital of the U.S.
Everyone in health care needs to get fired up about educating people on diabetes care.”
Read More »Issue 174 Item 9 Diabetes Self-Management Services Are Underutilized,
Even Where Widely Available Diabetes self-management training is underused in primary care, even where it’s readily available.
Read More »Issue 174 Item 10 Hormone Therapy Risks in Patients Taking Rosiglitazone
Rosiglitazone, used to control glycemic levels in type 2 diabetics, may not be as effective when administered in conjunction with hormone replacement therapy.
Read More »Issue 174 Item 11 Patients on Warfarin Advised Against Drinking Cranberry Juice
Patients taking warfarin should limit or avoid drinking cranberry juice because of the risk of hemorrhage.
Read More »Bone Is A Target For Rosiglitazone
Rosiglitazone administration results in significant bone loss.
Read More »Issue 174 Item 13 Beneficial Effect of Dark Chocolate in Older Hypertensive Pati
Eating dark not milk chocolate for 2 weeks produced a fall in blood pressure.
Read More »Issue 174 Item 14Early Control Predicts Diabetic Complication Risk
Early glucose and blood pressure control predict later complication risks in type 2 diabetes.
Read More »Issue 174 Item 15 Lifetime Diabetes Risk Is One In Three for Child Born in 2000
Male child has 33% risk; female, 39%, that from the CDC
Read More »Issue 173 Item 1 Diabetes Incidence Jumps 50 Percent in Past 10 Years-Obesity Ra
59% don’t know their risk for diabetes
Read More »